Mylan’s roots are in the U.S., and our products can likely be found in most American homes. In 2018 alone, our generics saved the nation’s healthcare system approximately $19 billion.

Access to Medicine

In 2018, Mylan generics saved Pennsylvania

~ $870 million

We believe everyone deserves the opportunity to live a healthy life, including you. That’s why our business is focused on providing a sustainable supply of high quality medicine that is accessible, acceptable, available and more affordable to patients around the world.

Innovation & Science

Mylan has global research centers in the U.S. and India and 10 technology-focused sites around the world.

Innovation and science are cornerstones of Mylan’s success for nearly 60 years.
They will continue to be the foundation of our future.

Public & Health Policy

One of the most powerful ways to serve patients in need is by speaking out on their behalf.

We work closely with government, trade associations, healthcare providers, patient advocacy groups and others to shape policy to help people in the U.S. enjoy better health.

Community Impact

The Robert J. Coury Global Center at Southpointe is a LEED-certified green building that houses our senior leaders in addition to functions including Finance, Human Relations, Information Technology, Marketing, Sales, Purchasing, Legal, Communications and others. It opened in 2013 and is located in Canonsburg, Pa.

Mylan person state
Workforce of
people in Pennsylvania
Mylan headquarters
Home to Mylan's U.S. Global Center
Mylan is committed to supporting organizations where we work and live. A few organizations we’ve supported in Pennsylvania include: Pittsburgh Promise, Pittsburgh Pride, the Boys and Girls Club of Western Pennsylvania and the Women’s Center and Shelter of Pittsburgh
Mylan comminuty charityupdated
Through one of our distribution partners, Dispensary of Hope, Mylan has donated ~2,359,936 doses of medicine to patients in Pennsylvania since 2012.

Mylan's School
Access Program - PA

Over the past six years, Mylan has provided 52,686 free epinephrine auto-injectors to 3,269 schools in Pennsylvania, ~63% of the state’s schools.

Several years ago, we recognized that epinephrine auto-injectors needed to be as accessible as defibrillators are in public spaces. So Mylan advocated for legislation to permit “undesignated” epinephrine auto-injectors in schools – meaning a prescription could be in a school’s name rather than in a child’s name and any individual experiencing an anaphylactic emergency would have access to the epinephrine auto-injectors. Today, 48 states have adopted such laws, and Mylan has donated more than 1 million epinephrine auto-injectors to more than 73,000 schools around the country through the school access program.

Since the program began, epinephrine auto-injectors provided through the program have been used at least 102 times in Pennsylvania in the school setting.